Large-scale genetic profiling of Philadelphia chromosome (Ph)-like ALL or BCR-ABL1-like ALL (Ph-positive ALL without BCR-ABL1 fusion protein) shows large number of genetic alterations in the cytokine receptor and kinase-signaling pathway genes that contribute to its aggressive phenotype and frequent disease recurrence [6, 7]. Here, BCR is linked to acute lymphoblastic leukemia.